c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors
Open Access
- 7 August 2018
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (61) , 31842-31860
Abstract
C-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumorsKeywords
This publication has 55 references indexed in Scilit:
- Plasma Cytokines Correlated With Disease Characteristics, Progression-Free Survival, and Overall Survival in Testicular Germ-Cell Tumor PatientsClinical Genitourinary Cancer, 2017
- The biology of germ cell tumors in disorders of sex developmentClinical Genetics, 2016
- An oncofetal and developmental perspective on testicular germ cell cancerSeminars in Cancer Biology, 2014
- Role of HGF–MET Signaling in Primary and Acquired Resistance to Targeted Therapies in CancerBiomedicines, 2014
- A direct role for Met endocytosis in tumorigenesisNature Cell Biology, 2011
- Hepatocyte Growth Factor (HGF) Modulates Leydig Cell Extracellular Matrix ComponentsJournal of Andrology, 2010
- Genetic aspects of testicular germ cell tumorsCell Cycle, 2008
- Absence of constitutional Y chromosome AZF deletions in patients with testicular germ cell tumorsUrology, 2005
- Expression profile of genes from 12p in testicular germ cell tumors of adolescents and adults associated with i(12p) and amplification at 12p11.2–p12.1Oncogene, 2003
- [Molecular characterization of hepatocyte growth factor (HGF)].1989